✦ LIBER ✦

Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: A phase III, randomized trial

✍ Scribed by Tinoco, Juan Carlos; Pavia-Ruz, Noris; Cruz-Valdez, Aurelio; Aranza Doniz, Carlos; Chandrasekaran, Vijayalakshmi; Dewé, Walthère; Liu, Aixue; Innis, Bruce L.; Jain, Varsha K.

Book ID: 122711009
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 603 KB
Volume: 32
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2014.01.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and safety of quadrivalen

Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults

✍ Jiří Beran, Mathieu Peeters, Walthère Dewé, Jolana Raupachová… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 248 KB

Safety and immunogenicity of a quadrival

Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults

✍ Greenberg, David P.; Robertson, Corwin A.; Noss, Michael J.; Blatter, Mark M.; B 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 360 KB

Safety and immunogenicity of a trivalent

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

✍ Scott A Halperin; Bruce Smith; Taoufik Mabrouk; Marc Germain; Pierre Trépanier; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Comparison of the immunogenicity and saf

Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults

✍ Robert W. Frenck Jr.; Robert Belshe; Rebecca C. Brady; Patricia L. Winokur; Jame 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 479 KB

A randomized, double-blind trial to eval

A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years

✍ T.F. Schwarz; J. Flamaing; H.C. Rümke; J. Penzes; C. Juergens; A. Wenz; D. Jayaw 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 281 KB

A prospective, randomized, open-label tr

A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older

✍ Bruce D. Forrest; A. Duncan Steele; Louis Hiemstra; Ruth Rappaport; Christopher 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 182 KB